TSHR and hyperthyroidism: Anti-TSHR antibodies [52], cyclic peptides [53] and small molecule ligands [54,55,56,57] are being developed as antagonists of TSHR activation with the potential to treat Graves’ hyperthyroidism and GO using the same drug.